Literature DB >> 25124562

Functional roles of long non-coding RNA in human breast cancer.

Ni Ye1, Bin Wang, Zi-Fang Quan, San-Jie Cao, Xin-Tian Wen, Yong Huang, Xiao-Bo Huang, Rui Wu, Xiao-Ping Ma, Qi-Gui Yan.   

Abstract

The discovery of long noncoding RNA (LncRNA) changes our view of transcriptional and posttranscriptional regulation of gene expression. With application of new research techniques such as high-throughput sequencing, the biological functions of LncRNAs are gradually becoming to be understood. Multiple studies have shown that LncRNAs serve as carcinogenic factors or tumor suppressors in breast cancer with abnormal expression, prompts the question of whether they have potential value in predicting the stages and survival rate of breast cancer patients, and also as therapeutic targets. Focusing on the latest research data, this review mainly summarizes the tumorigenic mechanisms of certain LncRNAs in breast cancer, in order to provide a theoretical basis for finding safer, more effective treatment of breast cancer at the LncRNA molecular level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25124562     DOI: 10.7314/apjcp.2014.15.15.5993

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  21 in total

1.  Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation.

Authors:  Jin Gao; Yuan Yuan; Lili Zhang; Shaorong Yu; Jianwei Lu; Jifeng Feng; Sainan Hu
Journal:  Cancer Cell Int       Date:  2020-03-23       Impact factor: 5.722

Review 2.  Long Noncoding RNA in Cancer: Wiring Signaling Circuitry.

Authors:  Chunru Lin; Liuqing Yang
Journal:  Trends Cell Biol       Date:  2017-12-20       Impact factor: 20.808

Review 3.  LncRNAs: key players and novel insights into cervical cancer.

Authors:  Li Peng; Xiaoqing Yuan; Binyuan Jiang; Zaili Tang; Guan-Cheng Li
Journal:  Tumour Biol       Date:  2015-12-29

4.  LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.

Authors:  Jing Ke; Quhui Wang; Wei Zhang; Sujie Ni; Haijun Mei
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 5.  Emerging ways to treat breast cancer: will promises be met?

Authors:  Pouria Samadi; Sahar Saki; Fatemeh Karimi Dermani; Mona Pourjafar; Massoud Saidijam
Journal:  Cell Oncol (Dordr)       Date:  2018-09-27       Impact factor: 6.730

Review 6.  A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.

Authors:  Sara Malih; Massoud Saidijam; Narges Malih
Journal:  Tumour Biol       Date:  2015-12-11

7.  Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia.

Authors:  Lianxiang Chen; Wei Wang; Lixia Cao; Zhijun Li; Xing Wang
Journal:  Mol Cells       Date:  2016-02-26       Impact factor: 5.034

8.  Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.

Authors:  Wenlei Li; Guotao Jia; Yanwen Qu; Qian Du; Baoguo Liu; Bin Liu
Journal:  Med Sci Monit       Date:  2017-07-13

Review 9.  Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer.

Authors:  Yancheng Zhong; Dan Gao; Shiwei He; Cijun Shuai; Shuping Peng
Journal:  Int J Gynecol Cancer       Date:  2016-11       Impact factor: 3.437

10.  LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451.

Authors:  Zhipeng Zhang; Hongxi Chen; Yebin Lu; Tiecheng Feng; Weijia Sun
Journal:  Int J Oncol       Date:  2018-02-28       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.